Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Francis I. Macedo"'
Autor:
Camille Baumrucker, Francis I. Macedo, Janelle Cheri Millen, Brianna L. Cohen, Dido Franceschi, Samantha Spring
Publikováno v:
Annals of Surgical Oncology. 28:2128-2135
With limited data in regards to management, occult breast cancer (OBC) poses a challenging surgical scenario. Current surgical management includes axillary lymphadenectomy (ALND) with or without mastectomy. We sought to investigate the impact of hosp
Autor:
Francis I. Macedo, Kristin N. Kelly, Amber L. Collier, Brianna L. Cohen, Dido Franceschi, Eli Avisar, Danny Yakoub, Neha Goel, Mecker G. Möller, Susan B. Kesmodel
Publikováno v:
Annals of Surgical Oncology. 27:1830-1841
Occult breast cancer (OBC) is a rare clinical entity. Current surgical management includes axillary lymphadenectomy (ALND) with or without mastectomy. We sought to investigate the role of sentinel lymph node biopsy (SLNB) in patients with OBC treated
Autor:
Jose Wilson Mesquita-Neto, Peter Cmorej, Francis I. Macedo, Steve Kim, Donald W. Weaver, Hassan Mouzaihem
Publikováno v:
The American Journal of Surgery. 219:181-184
The Affordable Care Act (ACA) expanded Medicaid eligibility to persons with income up to 138% of the federal poverty line. We investigated how Medicaid expansion (ME) impacted the access to cancer-specific surgical care in the US.We used a nationwide
Autor:
Dido Franceschi, Francis I. Macedo, Basem Azab, Jose Wilson Mesquita-Neto, Danny Yakoub, Nipun B. Merchant, Alan S. Livingstone, Kristin N. Kelly
Publikováno v:
Annals of Surgical Oncology. 27:662-670
Neoadjuvant chemotherapy (NAC) ± radiation (NRT) is the “gold standard” approach for locally advanced esophageal cancer (EC). However, the benefits of RT on overall survival (OS) in patients with resectable EC undergoing neoadjuvant therapy foll
Publikováno v:
Annals of surgical oncology. 28(8)
Autor:
Jose Wilson Mesquita-Neto, Nipun B. Merchant, William Dailey, Jayanth Manoharan, Francis I. Macedo
Publikováno v:
Annals of surgical oncology. 28(8)
The National Institutes of Health (NIH) is the primary public funding source for surgical research in the United States. Surgical oncology is a highly academic career, but NIH funding for surgical oncologists (SOs) is not well characterized. The NIH
Publikováno v:
Annals of surgical oncologyReference. 28(4)
Publikováno v:
Annals of surgery. 272(4)
OBJECTIVE The aim of this study was to assess the contemporary trends in National Institutes of Health (NIH) grants awarded to surgical investigators, including potential disparities. BACKGROUND The NIH remains the primary public funding source for s
Autor:
Camille C, Baumrucker, Samantha R, Spring, Brianna L, Cohen, Janelle-Cheri, Millen, Francis I, Macedo, Dido, Franceschi
Publikováno v:
Annals of surgical oncology. 28(4)
With limited data in regards to management, occult breast cancer (OBC) poses a challenging surgical scenario. Current surgical management includes axillary lymphadenectomy (ALND) with or without mastectomy. We sought to investigate the impact of hosp
Autor:
Alana Hofmann, Jose Wilson Mesquita-Neto, Francis I. Macedo, Jeffrey Rose, Janelle-Cheri A. Millen
Publikováno v:
The Journal of surgical research. 259
More effective chemotherapy regimens combined with metastasectomy have improved overall survival (OS) in several cancer populations. The value of liver resection (LR) in breast cancer liver metastasis (BCLM) remains controversial. We sought to invest